Roche’s one more attempts on Alzheimer’s disease therapies
In the Alzheimer’s disease therapy market, Roche was known to recently start domestic clinical trials one after another. Since they are clinical trials after experiencing failures on the two drugs for clinical trials in the past, the company attracted attention of the industry.
On July 7, the to...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
